Retraction Watch | Nature has added an “editor’s note” to a high-profile paper detailing how a team of researchers used CRISPR-Cas9 gene editing to correct a disease-causing mutation in viable human embryos, alerting readers to the fact that the article has been subject to criticism.

Bio-IT World Contributed Commentary | The move to collaborative research is one of the most fundamental changes occurring in life sciences discovery today. As biopharmaceutical companies engage more and more with each other, increased operational agility, reduced total cost of ownership, and improved global collaboration have become important keys to success.

Bio-IT World Brief | Synthego announces a new alignment with Thermo Fisher Scientific to manufacture and distribute world-class quality synthetic guide RNA products. Synthego’s synthetic guide RNA portfolio and synthetic guide RNA manufacturing capabilities will be utilized to produce synthetic guide RNAs under Thermo Fisher’s Invitrogen TrueGuide brand that will be marketed and sold across Thermo Fisher channels worldwide.

Bio-IT World Brief | HumanCode announced the launch of BABYGlimpse, the first DNA-powered app for couples to discover and explore the genetic-related traits their children may inherit.

Bio-IT World | Bio-IT World is accepting entries to the 2018 Bio-IT World Best Practices competition. For the past fifteen years, the Bio-IT World Best Practices Awards have highlighted outstanding examples of innovations and partnerships serving as powerful forces for change in the life sciences.

Bio-IT World Contributed Commentary | In the field of biobanking, where it is common for biobanks to evolve for different purposes, in disparate locations, and with isolated informatics systems, it’s no surprise that communication within and across biobanks, even within one institution, is challenging and fraught with miscommunications.

Bio-IT World Contributed Commentary | Next-generation sequencing continues to offer new hope for scientists and clinicians focused on everything from rare disease to cancer. Still, the clinical application of genomics could use some crucial improvements— perhaps none more urgent than standardized automated tools for genome interpretation.

Bio-IT World | In recent years, Celgene has been doubling down on its information analytics capabilities, and in January it launched an internal big data platform to more cohesively manage data to drive decision-making from pre-clinical research through commercialization.